Written answers
Tuesday, 16 October 2012
Department of Health
Medicinal Products Supply
Brendan Griffin (Kerry South, Fine Gael)
Link to this: Individually | In context | Oireachtas source
To ask the Minister for Health his plans to make the drug (details provided) available to cancer patients; and if he will make a statement on the matter. [44695/12]
Alex White (Dublin South, Labour)
Link to this: Individually | In context | Oireachtas source
On 15th October, 2012, the Minister for Health, Deputy James Reilly, announced that intensive negotiations with the Irish Pharmaceutical Healthcare Association (IPHA) had reached a successful conclusion with a major new deal on the cost of drugs in the State. This deal has a value in excess of €400 million over the next three years and will mean, amongst other things, greater access to new cutting-edge drugs. Accordingly, the HSE is finalising arrangements for the reimbursement of Abiraterone Acetate (Zytiga®) in line with the new agreement.
No comments